Tech Company Financing Transactions
Clover Biopharmaceuticals Funding Round
Clover Biopharmaceuticals closed a $24 million Series B funding round on 6/9/2020. Backers included GL Ventures.
Transaction Overview
Company Name
Announced On
6/9/2020
Transaction Type
Venture Equity
Amount
$24,000,000
Round
Series B
Investors
Proceeds Purpose
The funding will allow us to continue our efforts in expanding internal R&D capabilities and building a world-class team.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Building 1 Incubation Park Chengdu Hi-Tech Zone No. 1480 Nor B5-19
Chengdu Sichuan, 610041
China
Chengdu Sichuan, 610041
China
Phone
Website
Email Address
Overview
Founded by a team of world-class scientists returning to China, Clover Biopharmaceuticals is passionate about developing transformative biologic therapies for the millions of Chinese patients who currently do not have access to modern biological medicines.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 6/9/2020: ClassTag venture capital transaction
Next: 6/9/2020: HistoSonics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs